Microvascular Therapeutics

    OverviewSuggest Edit

    Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. The company has also follow-on products for molecular imaging and theranostic for cancer and heart disease.
    TypePrivate
    Founded2016
    Websitemvtpharma.com

    Latest Updates

    Employees (est.) (Mar 2020)2

    Microvascular Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2016
    Show all financial metrics

    Microvascular Therapeutics Online and Social Media Presence

    Embed Graph

    Microvascular Therapeutics Frequently Asked Questions

    • When was Microvascular Therapeutics founded?

      Microvascular Therapeutics was founded in 2016.

    • How many employees does Microvascular Therapeutics have?

      Microvascular Therapeutics has 2 employees.

    • Who are Microvascular Therapeutics competitors?

      Competitors of Microvascular Therapeutics include Oncovision, Eckert & Ziegler BEBIG and Blue Earth Diagnostics.